Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
13 Aug - 12 Oct 1993
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Guideline study with acceptable restrictions. There was no negative control for the 48-h sampling time, the purity of the test substance was not specified.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1993
Report date:
1993

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Version / remarks:
adopted Sep 2014
Deviations:
yes
Remarks:
no negative control group for the 48-h sampling time; purity of the test substance not specified
GLP compliance:
yes (incl. QA statement)
Remarks:
Bayerisches Staatsministerium für Arbeit, Familie und Sozialordnung, München
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
octadecyl heptanoate; octadecyl octanoate
EC Number:
915-334-0
Molecular formula:
C25H50O2 C26H52O2
IUPAC Name:
octadecyl heptanoate; octadecyl octanoate
Details on test material:
- Name of test material (as cited in study report): stearyl heptanoate (and) stearyl caprylate
- Physical state: waxy, colourless solid
- Analytical purity: no data
- Lot/batch No.: A:257032
- Storage condition of test material: at room temperature in the dark

Test animals

Species:
mouse
Strain:
other: Crl:NMRI BR
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Wiga, Sulzfeld, Germany
- Age at study initiation: adult (approximately 3 months)
- Weight at study initiation: 21 g ± 15%
- Assigned to test groups randomly: yes
- Housing: animals were housed in groups of 5 in Macrolon cages
- Diet: rat/mouse/hamster feed, pellets (Eggersmann Futtermittelwerk, Rinteln, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 6 - 7 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 2
- Humidity (%): 55 ± 10
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- Vehicle(s)/solvent(s) used: corn oil
- Amount of vehicle (if gavage or dermal): 10 mL/kg bw
Duration of treatment / exposure:
not applicable
Frequency of treatment:
single treatment
Post exposure period:
24 h after treatment (500 and 1500 mg/kg bw group)
24 and 48 h after treatment (5000 mg/kg bw group)
24 h after treatment (control groups)
Doses / concentrations
Remarks:
Doses / Concentrations:
500, 1500 and 5000 mg/kg bw
Basis:
actual ingested
No. of animals per sex per dose:
5
Control animals:
other: yes, concurrent vehicle. 2 negative control groups were used for the 24-hour sampling time and none for the 48-hour sampling time; no justification was given.
Positive control(s):
cyclophosphamide
- Route of administration: oral, gavage
- Doses / concentrations: 40 mg/kg bw

Examinations

Tissues and cell types examined:
Tissue: bone marrow
Cell type: bone marrow cells
Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION:
A range-finding study was performed to identify the maximum tolerated dose.

DETAILS OF SLIDE PREPARATION:
Slides were fixed with methanol for 5 minutes and stained with a May-Grünwald and Giemsa solution. Two slides per animal were prepared.

METHOD OF ANALYSIS:
A total of 1000 polychromatic erythrocytes were examined per slide and the number of micronucleated cells were recorded. The ratio of polychromatic erythrocytes to normochromatic (mature) erythrocytes was calculated for a sample of 1000 cells. All slides were randomised before analysis.
Evaluation criteria:
The frequency of micronuclei in the polychromatic erythrocytes and the ratio of polychromatic erythrocytes to normochromatic (mature) erythrocytes were compared with the negative control groups, the positive control group and the historical data.
Statistics:
The data were analysed using a likelihood ratio test. Individual animal results were used as data points in the analysis. The set of micronuclei in polychromatic erythrocytes among the control groups were compared with the set of each treatment time.

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
no effects
Vehicle controls validity:
valid
Negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
RESULTS OF RANGE-FINDING STUDY
- Dose range: 5000 mg/kg bw
- Clinical signs of toxicity in test animals: there were no signs of toxicity during the 48-h observation period
- Rationale for exposure: the dose was selected based on the maximum dose level recommended by regulatory bodies

RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): the number of polychromatic erythrocytes with or without micronuclei and the number of normochromatic erythrocytes in the treatment groups at different sampling times did not differ significantly from the number for the vehicle control groups and historical vehicle control data (see Table 1 - 4 under 'Any other information on results incl. tables').
- Ratio of PCE/NCE (for Micronucleus assay): the ratio for the treatment groups at different sampling times did not differ significantly from the ratio for the vehicle control groups and historical vehicle control data (see Table 1 - 4 under 'Any other information on results incl. tables').
- Other: no clinical signs were observed during the 48-h observation period.

Any other information on results incl. tables

Table 1: Results of the in vivo micronucleus assay in male animals

 

 

Mean

PCEs / 1000 NCEs

at sampling time

Total micronuclei

per 1000

PCEs at

sampling time

Group

Number

of animals

Dose [mg/kg bw]

24 h

48 h

24 h

48 h

Vehicle control I

(corn oil)

5

0

498.5 ± 54.4

n.d.

2.20 ± 1.10

n.d.

Vehicle control II

(corn oil)

5

0

507.4 ± 78.6

n.d.

2.20 ± 1.10

n.d.

Positive control

(cyclophosphamide)

5

40

555.0 ± 116.2

n.d.

41.8 ± 7.92

n.d.

Test substance

5

500

546.4 ± 125.5

n.d.

2.0 ± 1.22

n.d.

Test substance

5

1500

545.0 ± 81.9

n.d.

1.20 ± 0.84

n.d.

Test substance

5

5000

553.0 ± 68.9

582.2 ± 26.1

2.80 ± 1.10

2.20 ± 1.30

n.d. = not determined

 

 

Table 2: Results of the in vivo micronucleus assay in female animals

 

 

Mean

PCEs / 1000 NCEs

at sampling time

Total micronuclei

per 1000

PCEs at

sampling time

Group

Number

of animals

Dose [mg/kg bw]

24 h

48 h

24 h

48 h

Vehicle control I

(corn oil)

5

0

578.6 ± 39.9

n.d.

2.40 ± 1.14

n.d.

Vehicle control II

(corn oil)

5

0

557.6 ± 61.6

n.d.

2.40 ± 2.70

n.d.

Positive control

(cyclophosphamide)

5

40

557.8 ± 73.6

n.d.

29.2 ± 11.9

n.d.

Test substance

5

500

584.8 ± 70.6

n.d.

1.0 ± 1.41

n.d.

Test substance

5

1500

618.6 ± 45.7

n.d.

2.20 ± 1.64

n.d.

Test substance

5

5000

549.6 ± 88.6

526.4 ± 59.4

1.0 ± 0.71

2.20 ± 1.30

n.d. = not determined

 

Table 3: PCE/NCE ratio males and females

Treatment group

Dose

[mg/kg]

Sampling time

[h]

PCE/NCE ratio

Vehicle control I (corn oil)

0

24

1.20 ± 0.29

Vehicle control II (corn oil)

0

24

1.19 ± 0.35

Test substance

500

24

1.40 ± 0.50

Test substance

1500

24

1.46 ± 0.46

Test substance

5000

24

1.29 ± 0.39

Test substance

5000

48

1.27 ± 0.24

Positive control (Cyclophosphamide)

40

24

1.24 ± 0.53

 

Table 4: Historical data, vehicle controls

Parameter

Mean

Normal range

Number of polychromatic erythrocytes with micronuclei per 1000 polychromatic erythrocytes

 

 

Male

1.95 ± 1.02

< 3.99

Female

1.98 ± 0.76

< 3.50

Male and female

-

 

Ratio of polychromatic to normochromatic erythrocytes (1000)

 

 

Male

1.12 ± 0.34

0.44 - 1.88

Female

1.13 ± 0.20

0.73 - 1.53

Male and female

1.13 ± 0.27

0.59 - 1.67

 

   

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative